Regulator urges caution on painkillers, antibiotics
We haven't written up this one. The Economic Times has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
More in Health & Medicine
Are GLP-1s causing blindness? Novo Nordisk, Eli Lilly face lawsuits in US
The condition, known as nonarteritic anterior ischemic optic neuropathy (NAION), affects the optic nerve and can cause sudden, painless loss of vision.
IMO doctors vote to take industrial action
Doctors who are members of the Irish Medical Organisation (IMO) have voted in favour of industrial action, up to and including strike action.
Ozempic Causes Blindness? Patients Sue GLP-1 Drugmakers Over Rare Eye Condition Risk
GLP-1 medicines have become increasingly popular for managing type 2 diabetes and, in some cases, obesity and weight management.
These islands keep shifting so Assam made its healthcare mobile
NALBĀRI, Sept 22 — An infant lets out a feeble cry as a doctor administers a routine but vital injection aboard a...
People with Long COVID demand pause of McMaster University clinical trial
The trial, run by researchers at McMaster University in Canada, is testing the Lightning Process, a pseudoscientific mind-body program that outside experts have heavily criticized.
AstraZeneca’s pipeline strategy: building the next wave of growth
Delve into the AstraZeneca pipeline strategy in 2026 as its oncology franchise keeps growing and it invests in diversification.